Member Info for Latino

Agree why are these derampers here, need to have some class and have sensitivity towards the PIs who have taken a hit here. There is not much to deramp as this has already come right down..

Yes looks like about to leave the station...gla

News - second that. Garyn - you’re a naughty boy...haven’t done your homework! It’s ok we all make a few mistakes..

Yes it should now..gla

Garyn- where you’re chucking this 4.5M figure from...can’t see anywhere in interims? Hope it’s not a deramp and you can back it up...or else like the bod your credibility will also get a battering!

Don’t quite agree, RNS was excellent for a micro cap no one can deny that hence price rise. But placing I believe was arranged following this and agreed yesterday am hence the forward selling yesterday..

Thought it was very odd to bounce to 0.25 and then back down to 0.18 levels again. The rumour of it must have leaked at lunchtime yesterday..and all those sells in the afternoon. My hunch that a lot of these were forward sold yesterday and early today morning...gla

It’s the placing effect why this has dropped down so much...this should move up now.

Well I’m.m sure you have made bad investment decisions and so have I, the point is they know more and more hire professionals to advise them. It’s not to say they won’t get it wrong, and like you say previous investors lost out..look at FARN investors paid some £8-9 for these just last year! But they will get more right than wrong!

Game over..this is deramping at whole new level! Do you think investors are going to cough up near £3M quid if they didn’t believe they have a good chance now to get a positive decision...and no disrespect they know more than you and me with experts and consultants advising them..gla and keep calm!

Let’s not start speculating of what FDA are going to do lol Its the whole point behind the meeting! If they’ve decided already then they won’t be holding this meeting but instructing..PIs should know this!

Shorters last chance, opening is telling you all you need to know...Market likes it!

Correct, but you can’t still without evaluation can you?

Rns extract “..RMP is financially well placed to proceed with its evaluation plans for the Western Blocks and continue its ongoing evaluation of other opportunities, with a current cash balance of approximately AUD $4.6 million (excluding the refund associated with the performance bond). The process for the refund of the performance bond (RMP share USD$1.05 million) has begun, now that all obligations associated with it have been met..”

Why is it crap...and what were you expecting? Bod have told several times now that placing coming.

No funding required - read rns before posting. They have enough funds for next stage lol Oil is there and this is very encouraging, need to fjet the spot! This means that, whilst oil is present in the reservoir, there is less of it and it is not mobile. Further evaluation will be undertaken post drill to fully understand the implications of the petrophysical results.

2 months lol for fda approval! Rampers and shorters Out in force and like last week you lot are going to get cought out big time...when this moves it moves fast, with uncertainly removed and this already being way undervalued, it’s now only going one way..after first 1/2 blip...shorters watch out!

In my view this is excellent news, and let me tell you if FDA hasn’t agreed to the meeting last week...this placing wouldn’t have happened or at worse around 4p or something like that....in the scheme of things this is tiny placing and on approval bobs your uncle!

So not made an offer yet?

...and even better funding now beyond meeting until after the minutes so until June at least. Hugh risk removed and also importantly shows confidence in company securing approval from FDA..gla "We are encouraged by the support shown by both new and existing investors as we strengthen our balance sheet. The Company now expects to be funded through completion of the FDA meeting and receipt of the minutes, which should provide guidance regarding the path forward for iclaprim."